Skip to main content
Terug
CHE logo

Chemed Corporation

Datakwaliteit: 100%
Oversold
CHE
NYSE Healthcare Medical - Care Facilities
€ 374,02
▲ € 0,13 (0,03%)
Marktkapitalisatie: 5,28B
Dagbereik
€ 368,44 € 375,97
52-Weeksbereik
€ 368,44 € 623,61
Volume
349.724
50D / 200D Gem.
€ 435,41 / € 451,32
Vorige Slotkoers
€ 373,89

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (631 peers)

Metriek Aandeel Sector Mediaan
P/E 19,9 0,2
P/B 5,4 3,0
ROE % 25,3 3,6
Net Margin % 10,5 3,8
Rev Growth 5Y % 4,3 10,0
D/E 0,2 0,2

Koersdoel Analisten

Hold
€ 475,00 +27.0%
Forward K/W
15,67
Forward WPA
€ 23,88
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,67B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2028 € 28,90
€ 28,76 – € 29,06
3,00B 1
FY2027 € 26,62
€ 26,07 – € 27,17
2,83B 2
FY2026 € 23,88
€ 23,77 – € 23,97
2,67B 2

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-25 € 7,03 € 6,42 -8,7%
2025-10-28 € 5,39 € 5,27 -2,2%
2025-07-29 € 4,78 € 4,27 -10,7%
2025-04-23 € 5,55 € 5,63 +1,4%
2025-02-26 € 6,78 € 6,83 +0,7%
2024-10-29 € 5,76 € 5,64 -2,1%
2024-07-24 € 5,59 € 5,47 -2,1%
2024-04-24 € 5,48 € 5,20 -5,1%

Dividend History

7 yr streak

Yield

0,01%

Payout Ratio

0,12%

Growth (3Y)

14,13%

Growth (5Y)

10,76%

Ex-Date Payment Date Amount Yield
Feb 23, 2026 Mar 13, 2026 € 0,60 0,48%
Nov 17, 2025 Dec 05, 2025 € 0,60 0,51%
Aug 11, 2025 Aug 29, 2025 € 0,60 0,49%
May 29, 2025 Jun 17, 2025 € 0,50 0,35%
Feb 24, 2025 Mar 14, 2025 € 0,50 0,35%
Nov 18, 2024 Dec 06, 2024 € 0,50 0,32%
Aug 12, 2024 Aug 30, 2024 € 0,50 0,30%
May 30, 2024 Jun 18, 2024 € 0,40 0,29%
Feb 23, 2024 Mar 15, 2024 € 0,40 0,26%
Nov 10, 2023 Dec 04, 2023 € 0,40 0,27%
Aug 11, 2023 Sep 05, 2023 € 0,40 0,30%
May 24, 2023 Jun 14, 2023 € 0,38 0,28%
Feb 24, 2023 Mar 17, 2023 € 0,38 0,28%
Nov 10, 2022 Dec 05, 2022 € 0,38 0,30%
Aug 12, 2022 Sep 02, 2022 € 0,38 0,30%
May 25, 2022 Jun 15, 2022 € 0,36 0,29%
Feb 25, 2022 Mar 18, 2022 € 0,36 0,30%
Nov 12, 2021 Dec 06, 2021 € 0,36 0,28%
Aug 13, 2021 Sep 02, 2021 € 0,36 0,30%
May 26, 2021 Jun 16, 2021 € 0,34 0,27%

Belangrijkste Punten

Revenue grew 4,28% annually over 5 years — modest growth
Earnings declined -12,17% over the past year
ROE of 25,28% indicates high profitability
Debt/Equity of 0,16 — conservative balance sheet
Generating 325,48M in free cash flow
Cash machine — converts 122,71% of earnings into free cash flow

Groei

Revenue Growth (5Y)
4,28%
Revenue (1Y)4,06%
Earnings (1Y)-12,17%
FCF Growth (3Y)9,10%

Kwaliteit

Return on Equity
25,28%
ROIC22,37%
Net Margin10,48%
Op. Margin13,37%

Veiligheid

Debt / Equity
0,16
Current Ratio1,05
Interest Coverage193,28

Waardering

P/E Ratio
19,90
Forward P/E15,67
P/B Ratio5,39
EV/EBITDA15,84
Dividend Yield0,01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 4,06% Revenue Growth (3Y) 5,70%
Earnings Growth (1Y) -12,17% Earnings Growth (3Y) -1,34%
Revenue Growth (5Y) 4,28% Earnings Growth (5Y) -0,31%
Profitability
Revenue (TTM) 2,53B Net Income (TTM) 265,24M
ROE 25,28% ROA 16,17%
Gross Margin 29,97% Operating Margin 13,37%
Net Margin 10,48% Free Cash Flow (TTM) 325,48M
ROIC 22,37% FCF Growth (3Y) 9,10%
Safety
Debt / Equity 0,16 Current Ratio 1,05
Interest Coverage 193,28
Dividends
Dividend Yield 0,01% Payout Ratio 0,12%
Dividend Growth (3Y) 14,13% Dividend Growth (5Y) 10,76%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 19,90 Forward P/E 15,67
P/B Ratio 5,39 P/S Ratio 2,09
PEG Ratio -2,78 Forward PEG N/A
EV/EBITDA 15,84 Fwd EV/EBITDA 10,94
Forward P/S 1,98 Fwd Earnings Yield 6,38%
FCF Yield 6,17%
Market Cap 5,28B Enterprise Value 5,36B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,53B 2,43B 2,26B 2,13B 2,14B
Net Income 265,24M 302,00M 272,51M 249,62M 268,55M
EPS (Diluted) 18,42 19,89 17,93 16,53 16,85
Gross Profit 758,34M 854,35M 798,82M 765,09M 769,80M
Operating Income 338,25M 366,49M 340,57M 343,50M 343,04M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,64B 1,67B 1,67B 1,44B 1,34B
Total Liabilities 660,61M 549,58M 560,22M 643,30M 719,45M
Shareholders' Equity 979,41M 1,12B 1,11B 798,72M 623,27M
Total Debt 154,76M 140,84M 155,11M 247,01M 323,54M
Cash & Equivalents 74,52M 178,35M 263,96M 74,13M 32,90M
Current Assets 302,62M 394,75M 500,84M 272,61M 230,29M
Current Liabilities 287,13M 285,70M 312,05M 297,21M 302,40M